Adrian Hargrave, CEO of SEEEN, explains how the new funds will accelerate customer growth Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksETX.L Share News (ETX)

  • There is currently no data for ETX

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Tuesday broker round-up UPDATE

Tue, 14th May 2013 08:04

Babcock International: Jefferies increases target price from 1080p to 1250p and maintains a buy recommendation.Barratt Developments: Bank of America takes target price from 265p to 325p, while downgrading to neutral.Belgravium Technologies: WH Ireland places both its target price and its neutral rating under review.Bellway: Bank of America ups target price from 1135p to 1440p, while its neutral rating remains unchanged.Berkeley Group: Bank of America moves target price from 2183p to 2495p and retains a buy recommendation.Betfair Group: Investec increases target price from 585p to 750p, but still recommends selling.Blinkx: Citigroup ups target price from 115p to 130p and reiterates a buy recommendation.Bovis Homes Group: Bank of America increases target price from 695p to 800p, while downgrading to neutral.British Land: Panmure Gordon increases target price from 600p to 630p, while downgrading from buy to hold. Investec downgrades from buy to reduce with a target price of 600p.Capita: Panmure Gordon raises target price from 740p to 850p, but still recommends selling.Cranswick: Investec ups target price from 1095p to 1180p and retains a buy recommendation.Daily Mail & General Trust: Deutsche Bank revises target price from 630p to 660p and keeps a hold recommendation.Diploma: Jefferies raises target price from 615p to 690p and reiterates a buy recommendation.e-Therapeutics: Panmure Gordon shifts target price from 67p to 70p and stays with its buy recommendation.Halfords Group: N+1 Singer ups target price from 390p to 440p keeping a buy recommendation.Heritage Oil: Canaccord Genuity reduces target price from 350p to 300p, while reiterating its buy recommendation.Howden Joinery: Jefferies lowers target price from 200p to 186p and downgrades to underperform.ICAP: Canaccord Genuity upgrades from sell to hold with a target price of 300p.Imagination Technologies Group: Liberum Capital cuts target price from 415p to 330p keeping a hold recommendation.IMI: Investec takes target price from 1295p to 1355p, while its hold recommendation is reiterated.Interserve: JP Morgan shifts target price from 532p to 533p and keeps an overweight rating.Jarvis Securities: WH Ireland increases target price from 300p to 320p retaining a buy recommendation.Johnston Press: Panmure Gordon shifts target price from 20p to 25p, while leaving its buy recommendation unaltered.Laird: Espirito Santo reduces target price from 300p to 265p, while its buy recommendation is maintained.Lonmin: Westhouse Securities ups target price from 235p to 250p, but still recommends selling. Deutsche Bank takes target price from 365p to 395p, while staying with its hold recommendation.Man Group: Espirito Santo ups target price from 76p to 87p, but still recommends selling.Marks & Spencer: Panmure Gordon increases target price from 402p to 471p and keeps its buy recommendation.Mitchells & Butlers: Numis takes target price from 400p to 450p retaining an buy recommendation.Mothercare: N+1 Singer raises target price from 380p to 400p staying with its buy recommendation.Nature Group: WH Ireland shifts target price from 42p to 50p and reiterates its buy recommendation.Persimmon: Bank of America raises target price from 1120p to 1175p keeping its buy recommendation.Petropavlovsk: Westhouse Securities increases target price from 250p to 285p and stays with its buy recommendation. JP Morgan shifts target price from 420p to 430p retaining an overweight rating. Numis shifts target price from 290p to 300p and leaves its buy recommendation unaltered.Premier Oil: Deutsche Bank cuts target price from 615p to 600p leaving its buy recommendation unchanged.Rathbone Brothers: Canaccord Genuity downgrades from buy to hold with a target price of 1500p.Redrow: Bank of America revises target price from 220p to 300p maintaining a buy recommendation.Rio Tinto: UBS cuts target price from 4590p to 4550p and stays with its buy recommendation.SIG: Jefferies shifts target price from 185p to 190p keeping a buy recommendation.Smith & Nephew: Berenberg shifts target price from 805p to 810p, while downgrading from buy to hold. Investec revises target price from 755p to 776p and stays with its add recommendation.Standard Chartered: Citigroup reduces target price from 1900p to 1775p, while its buy recommendation remains unaltered.St. James's Place: Credit Suisse ups target price from 520p to 600p and reiterates a neutral rating.Taylor Wimpey: Bank of America moves target price from 75p to 115p upgrading to buy.Travis Perkins: Jefferies lowers target price from 1130p to 1120p downgrading to underperform.TUI Travel: Jefferies ups target price from 300p to 315p reiterating its hold recommendation. JP Morgan shifts target price from 350p to 360p, while downgrading to neutral.Wetherspoon (JD): Investec takes target price from 550p to 660p and maintains a buy recommendation.Wolseley: Jefferies moves target price from 2540p to 2520p and leaves its underperform recommendation unchanged.
More News
8 May 2014 10:51

e-Therapeutics Trading Up As Brain Cancer Trial To Resume Recruitment

LONDON (Alliance News) - Shares in e-Therapeutics PLC were trading higher Thursday after it said that it had been cleared by the US Food and Drug administration to resume recruiting patients for its Phase Ia study of compound ETS2101 in brain cancer. The company had previously paused recrui

Read more
7 Apr 2014 12:25

UPDATE: e-Therapeutics Appoints Steve Medlicott Chief Financial Officer

LONDON (Alliance News) - e-Therapeutics PLC Monday said that it had appointed Steve Medlicott as Chief Financial Officer, following the resignation of Daniel Elger with immediate effect, also announced Monday. Medlicott had advised the company on its GBP40 million fund-raising in 2013. Medl

Read more
7 Apr 2014 10:57

e-Therapeutics's Chief Financial Officer Daniel Elger Resigns

LONDON (Alliance News) - e-Therapeutics PLC Monday said that Daniel Elger has resigned as Chief Financial officer and a director of the company, with immediate effect. e-Therapeutics said that the company's finances will be managed on an interim basis by Paul Stockdale, who has been the com

Read more
31 Mar 2014 12:50

REPEAT: UK MIDDAY BRIEFING: Babcock JV Wins GBP7 Billion Nuclear Contract

LONDON (Alliance News) - Babcock International Group is leading the FTSE 100 higher Monday after its Cavendish Fluor Partnership joint venture was selected as the preferred bidder for a GBP7 billion nuclear plant decommissioning contract.

The joint venture with Fluo

Read more
31 Mar 2014 12:45

UK MIDDAY BRIEFING: Babcock JV Wins GBP7 Billion Nuclear Contract

LONDON (Alliance News) - Babcock International Group is leading the FTSE 100 higher Monday after its Cavendish Fluor Partnership joint venture was selected as the preferred bidder for a GBP7 billion nuclear plant decommissioning contract.

The joint venture with Flou

Read more
31 Mar 2014 10:35

UK WINNERS & LOSERS: Babcock Leads FTSE 100 Risers; Insurers Rebound

LONDON (Alliance News) - The following stocks are the leading risers and fallers within the main London indices midday Monday.

-------

FTSE 100 - WINNERS

Babcock International Group, up 3.5%. The company said its Cavendish Fluor Partnership has

Read more
31 Mar 2014 08:33

e-Therapeutics Rises As It Gets Good Interim Drug Trial Results

LONDON (Alliance News) - e-Therapeutics PLC Monday said it had achieved positive interim results from a UK study evaluating the safety, dosing and anti-tumour activity of its ETS2101 drug in patients with advanced solid cancer tumours. In a statement, the company said that it had completed

Read more
26 Mar 2014 13:40

UK MIDDAY BRIEFING: Government Completes 2nd Lloyds Bank Stake Sale

LONDON (Alliance News) - The UK government has raised a further GBP4.20 billion from its second sale of Lloyds Banking Group PLC shares, meaning it has now recouped GBP7.41 billion of the roughly GBP21 million that taxpayers injected into the bank during the financial crisis.<

Read more
26 Mar 2014 11:30

UK WINNERS & LOSERS: Standard Life Leads FTSE 100 Risers

LONDON (Alliance News) - The following stocks are the leading risers and fallers within the main London indices midday Wednesday.

-------

FTSE 100 - WINNERS

Standard Life, up 5.2%. The company has agreed to buy Ignis Asset Mana

Read more
26 Mar 2014 11:03

e-Therapeutics Gains As Recruitment For Cancer Trial Resumes

LONDON (Alliance News) - Shares in e-Therapeutics PLC jumped Wednesday morning after the biotechnology company said it has received approval from MHRA to recommence recruitment of new patients into its ETS2101 phase Ia solid tumours trial. Recruitment for the trial was temporarily paused ov

Read more
24 Jan 2014 12:41

UK MIDDAY BRIEFING: Bank Of England Now Focused On Productivity

LONDON (Alliance News) - Bank of England Governor Mark Carney Friday signaled that rising productivity will now be the key factor that decides when the central bank will start to tighten monetary policy, and any tightening will be a slow, gradual process.

In a speech at the World Ec

Read more
24 Jan 2014 11:01

e-Therapeutics Temporarily Halts Recruitment In Trial Due To Drug Supply Issue

LONDON (Alliance News) - Shares in e-Therapeutics PLC dropped 16% Friday morning after it said that it was temporarily halting recruitment into its ETS2101 cancer trials due to a drug supply issue. e-Therapeutics said that there had been a practical issue with the stored drugs for the trial

Read more
24 Jan 2014 10:58

UK WINNERS & LOSERS: Cairn Falls As Indian Tax Department Gets In Touch

LONDON (Alliance News) - The following stocks are the leading risers and fallers within the main London indices midday Friday. ------- FTSE 100 - WINNERS Weir Group, up 0.2%. The engineering company said it had won a USD98 million, or GBP59 million, two-year contract to provide

Read more
7 Jan 2014 08:22

AIM IN BRIEF: H&T Says Profit As Expected, But Gold Price Has Hurt

Read more
31 Oct 2013 13:36

e-Therapeutics Starts Phase IIb Trial Of Depressive Disorder Treatment

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.